ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,154Medicare Part D Prescriptions Filled, Including Refills

Rank: 328 out of 3001

$800K Total Retail Price of All Prescriptions

Rank: 205 out of 3001

360 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 10,883 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
CITALOPRAM HBR 615 609 1 16
FUROSEMIDE 545 535 2 6
LEVOTHYROXINE SODIUM 456 452 3 3
LISINOPRIL 407 400 4 2
NAMENDA 370 370 5 40
DONEPEZIL HCL 293 293 6 27
HYDROCODONE-ACETAMINOPHEN 281 244 S3 7 7
SIMVASTATIN 272 268 8 1
MIRTAZAPINE 272 271 8 44
CARBIDOPA-LEVODOPA 261 261 10 97
WARFARIN SODIUM 255 255 11 12
OMEPRAZOLE 202 201 12 4
SERTRALINE HCL 200 199 13 20
METOPROLOL TARTRATE 168 167 14 8
METOPROLOL SUCCINATE 167 167 15 19
POTASSIUM CHLORIDE 164 162 16 15
BUMETANIDE 151 151 17 151
CYMBALTA 140 138 18 53
EXELON 125 125 19 108
ALLOPURINOL 119 119 20 35
TRAMADOL HCL 116 114 21 17
AMLODIPINE BESYLATE 116 112 21 5
ISOSORBIDE MONONITRATE ER 111 109 23 45
CARVEDILOL 100 94 24 25
ATENOLOL 99 99 25 18
SPIRONOLACTONE 99 99 25 75
METFORMIN HCL 93 90 27 9
HYDROCHLOROTHIAZIDE 89 86 28 10
PANTOPRAZOLE SODIUM 88 88 29 43
PLAVIX 81 78 30 46
ALENDRONATE SODIUM 80 80 31 26
RISPERIDONE 76 76 32 63
TAMSULOSIN HCL 74 69 33 29
DIGOXIN 73 73 34 65
LANTUS 70 64 35 47
GABAPENTIN 67 63 36 14
LOSARTAN POTASSIUM 67 67 36 21
ATORVASTATIN CALCIUM 66 64 38 11
FENTANYL 64 64 S2 39 76
OXYCODONE-ACETAMINOPHEN 63 63 S2 40 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 60 41 22
ZOLPIDEM TARTRATE 58 58 42 24
DOXYCYCLINE HYCLATE 58 57 42 105
AMANTADINE 58 58 42 312
TRAZODONE HCL 57 50 45 37
JANTOVEN 56 49 46 110
CLOPIDOGREL 54 54 47 28
ROPINIROLE HCL 54 53 47 88
PREDNISONE 52 51 49 39
FLUTICASONE PROPIONATE 51 51 50 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.